These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8684214)
41. [Value of serological determinations in the differential diagnosis of ulcerative colitis and Crohn's disease, and immunogenetic aspects]. Oudkerk Pool M; Bouma G; Kolkman JJ; Meuwissen SG; von Blomberg BM; Peña AS Ned Tijdschr Geneeskd; 1994 Dec; 138(50):2483-7. PubMed ID: 7800073 [No Abstract] [Full Text] [Related]
42. Factors determining the occurrence of serum agglutinins to eubacterium and peptostreptococcus species in patients with Crohn's disease and ulcerative colitis. van de Merwe JP; Mol GJ; Wensinck F; Dees J; van Blankenstein M; Westbroek DL Digestion; 1982; 23(2):104-9. PubMed ID: 7095311 [TBL] [Abstract][Full Text] [Related]
43. [Antibodies to cytomegalovirus in ulcerative colitis and in Crohn's disease (author's transl)]. Bernades P; Nataf C; Ferchal F; Colimon R Gastroenterol Clin Biol; 1980 Feb; 4(2):128-33. PubMed ID: 6245008 [No Abstract] [Full Text] [Related]
44. [Major histocompatibility complex in ulcerative colitis and Crohn's disease]. Tsuchiya M; Ono A; Asakura H; Mizuno Y; Aiso S Nihon Rinsho; 1978 Sep; 36(9):3151-8. PubMed ID: 364102 [No Abstract] [Full Text] [Related]
45. [Lipid A antibody titers and O antibody titers in Crohn's disease, ulcerative colitis and acute enteritis (author's transl)]. Schüssler P; Kruis W; Marget W Med Klin; 1976 Oct; 71(44):1898-902. PubMed ID: 825710 [TBL] [Abstract][Full Text] [Related]
46. [Ulcerative colitis and Crohn disease from the immunologic viewpoint]. Storch W Z Gesamte Inn Med; 1993 Feb; 48(2):49-51. PubMed ID: 8465545 [TBL] [Abstract][Full Text] [Related]
47. Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls. Scott MG; Nahm MH; Macke K; Nash GS; Bertovich MJ; MacDermott RP Clin Exp Immunol; 1986 Oct; 66(1):209-15. PubMed ID: 3802572 [TBL] [Abstract][Full Text] [Related]
48. [Characteristics of the course of periodontal diseases in patients with nonspecific ulcerative colitis and Crohn's disease]. Danilevskiĭ NF; Zavernaia AM; Tkachuk NN; Mokhort VV Stomatologiia (Mosk); 1987; 66(3):20-2. PubMed ID: 3475823 [No Abstract] [Full Text] [Related]
49. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity. Lyanga J; Davis P; Thomson AB West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844 [TBL] [Abstract][Full Text] [Related]
50. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation. Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017 [TBL] [Abstract][Full Text] [Related]
51. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Seibold F; Weber P; Jenss H; Wiedmann KH Gut; 1991 Oct; 32(10):1192-7. PubMed ID: 1955175 [TBL] [Abstract][Full Text] [Related]
53. Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis. Doe WF; Booth CC; Brown DL Lancet; 1973 Feb; 1(7800):402-3. PubMed ID: 4119709 [No Abstract] [Full Text] [Related]
54. Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization. Brown DJ; Jewell DP Clin Exp Immunol; 1982 Jul; 49(1):67-74. PubMed ID: 6982133 [TBL] [Abstract][Full Text] [Related]
55. [Changes in the immune system of the gastrointestinal tract in Crohn disease]. Voss A; Steffen M Immun Infekt; 1990 Aug; 18(4):111-4. PubMed ID: 2210792 [TBL] [Abstract][Full Text] [Related]
56. [Some clinical aspects of ulcerative colitis and Crohn's diseases in children]. Mryglodowicz A; Ejsmont L; Grabowska-Lubaszko U Pediatr Pol; 1974 Apr; 49(4):393-9. PubMed ID: 4827677 [No Abstract] [Full Text] [Related]
57. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844 [TBL] [Abstract][Full Text] [Related]
58. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634 [TBL] [Abstract][Full Text] [Related]
59. [Serodiagnosis of Crohn's disease]. Auer IO; Wensinck F; Röder A; Merwe JP; Schmidt H; Schuster S Dtsch Med Wochenschr; 1983 Aug; 108(33):1242-6. PubMed ID: 6872878 [TBL] [Abstract][Full Text] [Related]
60. A morphological assessment of immunoreactivity in colonic Crohn's disease and ulcerative colitis by a study of the lymph nodes. Skinner JM; Whitehead R J Clin Pathol; 1974 Mar; 27(3):202-6. PubMed ID: 4598882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]